Viewing Study NCT04176367


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2026-01-01 @ 4:34 AM
Study NCT ID: NCT04176367
Status: COMPLETED
Last Update Posted: 2021-01-27
First Post: 2019-11-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module